Aktiesnakken — Februar 2011
-
simcorps rapport ude til at fordrive ventetiden med genmab
-
udbytte...på 0 k
-
30 dkk
-
omsætningen skuffer
-
men margin er som lovet
-
spaltning
-
?
-
det som jv, aka og andre mener med at vi alle skal arbejde hårdere for at redde dk? 3-4jobs samtidig er måske lige i overkanten
-
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind